1 / 2

Multiplex Assay Market

Multiplex Assay Market size is estimated to be USD 77.8 million in 2019 and is predicted to reach USD 153.9 million by 2030.

Télécharger la présentation

Multiplex Assay Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.


Presentation Transcript

  1. Multiplex Assay Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2030 High prevalence rate of various disorders supported by the surge in companion diagnostics along with technological advancement as well as growing inclination towards personalized medicines are key drivers for Global Multiplex Assay Market. Multiplex Assay Market is valued around USD 77.8 Million in 2019 and expected to reach USD 153.9 Million by 2030 with the CAGR of 6.4% over the forecast period. Multiplex assay is a technique used by the scientist, biotechnologists & others to identify various different components from the biological sample. These methods involve the quantification of the sample to get the maximum information about the sample which is available in minute quantity. It helps in the various forensic & research study for the detection of various disorders as it is much reliable as well as less time consuming. Global Multiplex Assay Market report is segmented on the basis of product, type, technology, application, end user and by regional. Based upon product, the multiplex assay market is fragmented into Multiplex Assay Reagents & Consumables, Multiplex Assay Instruments & Accessories, and Multiplex Assay Software & Services. On the basis of type, the market is categorized into Nucleic Acid-based Multiplex Assays, Protein-based Multiplex Assays, and Others. Based on technology, the market is fragmented into Multiplex PCR, multiplex protein microarray, and others. On the basis of application, the market is categorized into companion diagnostics, research & development, and clinical diagnostics. Based on end user, the market is divided into Hospitals, Clinical Laboratories, Research Institutes, and Pharmaceuticals & Biotechnological Companies. The regional bifurcation of countries includes North America, Europe, Asia-Pacific, and RoW which are further segmented into major countries such as U.S., UK, France, and others. The multiplex assays market is mainly driven by the constant development of healthcare facilities followed by the high prevalence rate of various disorders. There has been technological advancement associated with several advantages offered by the advanced technology in terms of time, result, reliability & others. There has been constant growth in the adoption of companion diagnostics associate with several benefits followed by high demand for safe & effective treatment. On the other hand, high adoption rate of personalized medicine followed by the rising clinical trials supported by the growth in contract research organization. However, stringent regulatory policies for the approval along with the high cost associated with the instruments can restrain the market growth. Download sample copy of this report at https://www.nextmsc.com/multiplex-assay- market/request-sample The developed regions such as North America and Europe are expected to hold the major market share owing to the presence of developed healthcare facilities supported by the presence of contract research organization. Moreover, presence of advanced technology

  2. along with high adoption rate of companion diagnostics is also expected to enhance the market growth. Asia Pacific is expected to dominate the multiplex assay market in terms of growth rate owing to the developing prevalence rate of various disorders as well as growing inclination towards personalized medicines. In addition, high demand for safe & effective treatment therapies with new product launches in the region may support the market growth. The major market players profiled in the multiplex assay market includes market Thermo Fisher Scientific Inc., Luminex Corporation, Bio-Rad Laboratories Inc., Illumina Inc., Becton, Dickinson and Company, QIAGEN N.V., Seegene Inc., Abcam PLC, Randox Laboratories Ltd. and Meso Scale Diagnostics LLC among others. About Us: Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics. We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses. Contact US: Joseph Lawrence (Head - Client Engagement & Servicing) Joseph@nextmsc.com

More Related